525596-66-1,MFCD19690907
Catalog No.:AA00DLTA

525596-66-1 | bPiDDB

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
95%
1 week  
$120.00   $84.00
- +
10mg
95%
1 week  
$168.00   $118.00
- +
25mg
95%
1 week  
$284.00   $199.00
- +
50mg
95%
1 week  
$391.00   $274.00
- +
100mg
95%
1 week  
$552.00   $387.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DLTA
Chemical Name:
bPiDDB
CAS Number:
525596-66-1
Molecular Formula:
C24H38Br2N2
Molecular Weight:
514.3799
MDL Number:
MFCD19690907
SMILES:
Cc1ccc[n+](c1)CCCCCCCCCCCC[n+]1cccc(c1)C.[Br-].[Br-]
Properties
Computed Properties
 
Complexity:
298  
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
13  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Literature

Title: Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters 20110101

Title: Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.

Journal: Biochemical pharmacology 20100801

Title: Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter.

Journal: Bioorganic & medicinal chemistry letters 20100601

Title: Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters 20100215

Title: Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Journal: Bioorganic & medicinal chemistry letters 20100201

Title: The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.

Journal: Biochemical pharmacology 20091001

Title: QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.

Journal: Bioorganic & medicinal chemistry 20090701

Title: Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Journal: Nebraska Symposium on Motivation. Nebraska Symposium on Motivation 20090101

Title: Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090101

Title: The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.

Journal: European journal of pharmacology 20081228

Title: Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters 20081101

Title: bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporter.

Journal: Bioorganic & medicinal chemistry letters 20081015

Title: Pharmacokinetics of the novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide in the rat.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20081001

Title: N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.

Journal: The Journal of pharmacology and experimental therapeutics 20080801

Title: Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.

Journal: British journal of pharmacology 20080201

Title: Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier.

Journal: The Journal of pharmacology and experimental therapeutics 20080101

Title: Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters 20071215

Title: Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation.

Journal: Bioorganic & medicinal chemistry letters 20071215

Title: The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.

Journal: Neuropharmacology 20070301

Title: Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.

Journal: Psychopharmacology 20060301

Title: Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.

Journal: Bioorganic & medicinal chemistry letters 20040419

Title: bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.

Journal: Bioorganic & medicinal chemistry letters 20021104

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 525596-66-1
Tags:525596-66-1 Molecular Formula|525596-66-1 MDL|525596-66-1 SMILES|525596-66-1 bPiDDB
Catalog No.: AA00DLTA
525596-66-1,MFCD19690907
525596-66-1 | bPiDDB
Pack Size: 5mg
Purity: 95%
1 week
$120.00 $84.00
Pack Size: 10mg
Purity: 95%
1 week
$168.00 $118.00
Pack Size: 25mg
Purity: 95%
1 week
$284.00 $199.00
Pack Size: 50mg
Purity: 95%
1 week
$391.00 $274.00
Pack Size: 100mg
Purity: 95%
1 week
$552.00 $387.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DLTA
Chemical Name: bPiDDB
CAS Number: 525596-66-1
Molecular Formula: C24H38Br2N2
Molecular Weight: 514.3799
MDL Number: MFCD19690907
SMILES: Cc1ccc[n+](c1)CCCCCCCCCCCC[n+]1cccc(c1)C.[Br-].[Br-]
Properties
Complexity: 298  
Covalently-Bonded Unit Count: 3  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 28  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 13  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Literature fold

Title: Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters20110101

Title: Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.

Journal: Biochemical pharmacology20100801

Title: Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter.

Journal: Bioorganic & medicinal chemistry letters20100601

Title: Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters20100215

Title: Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Journal: Bioorganic & medicinal chemistry letters20100201

Title: The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.

Journal: Biochemical pharmacology20091001

Title: QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.

Journal: Bioorganic & medicinal chemistry20090701

Title: Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Journal: Nebraska Symposium on Motivation. Nebraska Symposium on Motivation20090101

Title: Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20090101

Title: The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.

Journal: European journal of pharmacology20081228

Title: Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters20081101

Title: bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporter.

Journal: Bioorganic & medicinal chemistry letters20081015

Title: Pharmacokinetics of the novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide in the rat.

Journal: Drug metabolism and disposition: the biological fate of chemicals20081001

Title: N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.

Journal: The Journal of pharmacology and experimental therapeutics20080801

Title: Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.

Journal: British journal of pharmacology20080201

Title: Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier.

Journal: The Journal of pharmacology and experimental therapeutics20080101

Title: Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.

Journal: Bioorganic & medicinal chemistry letters20071215

Title: Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation.

Journal: Bioorganic & medicinal chemistry letters20071215

Title: The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.

Journal: Neuropharmacology20070301

Title: Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.

Journal: Psychopharmacology20060301

Title: Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.

Journal: Bioorganic & medicinal chemistry letters20040419

Title: bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.

Journal: Bioorganic & medicinal chemistry letters20021104

Building Blocks More >
51757-47-2
51757-47-2
5-(2-Adamantylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione
AA00DMJ5 | MFCD00167792
460044-83-1
460044-83-1
2-Amino-6-Nitrobenzo[d]thiazol-4-ol
AA00DO81 | MFCD02765681
5411-11-0
5411-11-0
2-(4-Chloro-2-isopropyl-5-methylphenoxy)acetic acid
AA00DQDJ | MFCD01038351
49629-37-0
49629-37-0
2-(4-methoxybenzylidene)-1,2,3,4-tetrahydronaphthalen-1-one
AA00DS3L | MFCD00019683
50598-33-9
50598-33-9
3-ethyldihydro-3-methylfuran-2,5-dione
AA00DU8O | MFCD11134367
477334-39-7
477334-39-7
3-((4-Fluorophenyl)thio)-1-(naphthalen-2-yl)propan-1-one
AA00DW1N | MFCD03934773
536-13-0
536-13-0
kerasin
AA00DZ2I
551-88-2
551-88-2
3-NITROPENTANE
AA00E08H | MFCD02752157
50995-52-3
50995-52-3
(7-METHOXY-2-METHYL-1H-INDOL-3-YL)-ACETIC ACID
AA00E1O4 | MFCD09863997
54951-54-1
54951-54-1
N-(4-(N,N-Dimethylsulfamoyl)phenyl)acetamide
AA00E4MC | MFCD01213968
Submit
© 2017 AA BLOCKS, INC. All rights reserved.